Pleuroparenchymal abnormalities in cancer patients undergoing CTPA for suspected pulmonary embolism.
- 1Faculty of Medicine, Al-Quds University, Jerusalem, Palestine.
- 2Head of the Department of Anesthesia, Augusta Victoria Hospital, Jerusalem, Palestine.
- 3Department of Radiology, St. Vincent's University Hospital, Dublin, Ireland.
Abstract
Objectives
To characterize pleuroparenchymal abnormalities identified on computed tomography pulmonary angiography (CTPA) in cancer patients investigated for suspected pulmonary embolism (PE) and to compare imaging findings between patients with and without confirmed PE.Methods
This single-center retrospective observational study included 113 consecutive cancer patients who underwent CTPA for suspected acute PE between January 2022 and January 2026. Radiology reports and electronic medical records were reviewed for demographic data, malignancy type and stage, PE-related imaging characteristics, and pleural and pulmonary parenchymal abnormalities. Imaging findings were compared between PE-positive and PE-negative groups. An exploratory multivariable model with a restricted set of imaging predictors was constructed to limit overfitting, with correction for multiple comparisons and bootstrap-based internal validation. Exploratory subgroup analyses by malignancy type and disease burden were also performed.Results
PE was confirmed in 32 patients (28.3%). The median age was 59 years (IQR, 51-65), and 42.5% were female. The highest PE prevalence was observed in gastrointestinal, gynecologic, and thoracic malignancies. At nominal testing, infarct-like wedge-shaped opacity was more frequent in PE-positive patients (12.5% vs. 1.2%; OR, 11.43; p = 0.022), whereas ground-glass opacity (15.6% vs. 35.8%; OR, 0.33; p = 0.041) and interstitial/septal change (3.1% vs. 25.9%; OR, 0.09; p = 0.007) were less frequent. None remained statistically significant after false-discovery-rate correction (q = 0.133, 0.166, and 0.082, respectively). The parsimonious model had an apparent AUROC of 0.707 and an optimism-adjusted AUROC of 0.699, with acceptable grouped calibration (Hosmer-Lemeshow p = 0.522). No exploratory cancer-subgroup comparison met q < 0.05.Conclusions
Pleuroparenchymal abnormalities are highly prevalent in cancer patients undergoing CTPA for suspected PE; however, most findings are nonspecific. Infarct-like wedge-shaped opacity generated the strongest exploratory PE-associated signal, but no individual imaging comparison survived multiplicity correction and model estimates remained imprecise. These findings should therefore be considered hypothesis-generating and require validation in larger cohorts.
Related
- Pleuroparenchymal Fibroelastosis Lesion in Explanted Lungs of a Patient with Fibrotic Pulmonary Sarcoidosis
- Clinically relevant chromosomal abnormalities and chromosomal polymorphisms in 7,530 patients undergoing reproductive genetic counseling: a retrospective cytogenetic study in a Chinese Han population
- Prognostic value of pulmonary artery pulsatility index for perioperative adverse cardiovascular events in patients undergoing surgery for mitral regurgitation
- Prognostic impact of surgical-side pulmonary artery diameter in patients with non-small cell lung cancer undergoing lobectomy
- Prevalence and factors associated with pulmonary hypertension in patients undergoing maintenance hemodialysis: a systematic review and meta-analysis
BibTeX
@article{allahham2026pleuroparenchymal,
title = {{Pleuroparenchymal abnormalities in cancer patients undergoing CTPA for suspected pulmonary embolism.}},
author = {Mohammad F Allahham and Haya Mustafa and Jana Faroun and Alhareth M Amro and Fuad M Allahham and Oadi N Shrateh and David Murphy},
journal = {Frontiers in radiology},
year = {2026},
month = oct,
doi = {10.3389/fradi.2026.1901919},
url = {https://europepmc.org/article/MED/42948082},
note = {CC BY},
}
RIS
TY - JOUR
TI - Pleuroparenchymal abnormalities in cancer patients undergoing CTPA for suspected pulmonary embolism.
AU - Mohammad F Allahham
AU - Haya Mustafa
AU - Jana Faroun
AU - Alhareth M Amro
AU - Fuad M Allahham
AU - Oadi N Shrateh
AU - David Murphy
PY - 2026
DA - 2026/10/13
JO - Frontiers in radiology
DO - 10.3389/fradi.2026.1901919
UR - https://europepmc.org/article/MED/42948082
AB - Objectives To characterize pleuroparenchymal abnormalities identified on computed tomography pulmonary angiography (CTPA) in cancer patients investigated for suspected pulmonary embolism (PE) and to compare imaging findings between patients with and without confirmed PE.Methods This single-center retrospective observational study included 113 consecutive cancer patients who underwent CTPA for suspected acute PE between January 2022 and January 2026. Radiology reports and electronic medical records were reviewed for demographic data, malignancy type and stage, PE-related imaging characteristics, and pleural and pulmonary parenchymal abnormalities. Imaging findings were compared between PE-positive and PE-negative groups. An exploratory multivariable model with a restricted set of imaging predictors was constructed to limit overfitting, with correction for multiple comparisons and bootstrap-based internal validation. Exploratory subgroup analyses by malignancy type and disease burden were also performed.Results PE was confirmed in 32 patients (28.3%). The median age was 59 years (IQR, 51-65), and 42.5% were female. The highest PE prevalence was observed in gastrointestinal, gynecologic, and thoracic malignancies. At nominal testing, infarct-like wedge-shaped opacity was more frequent in PE-positive patients (12.5% vs. 1.2%; OR, 11.43; p = 0.022), whereas ground-glass opacity (15.6% vs. 35.8%; OR, 0.33; p = 0.041) and interstitial/septal change (3.1% vs. 25.9%; OR, 0.09; p = 0.007) were less frequent. None remained statistically significant after false-discovery-rate correction (q = 0.133, 0.166, and 0.082, respectively). The parsimonious model had an apparent AUROC of 0.707 and an optimism-adjusted AUROC of 0.699, with acceptable grouped calibration (Hosmer-Lemeshow p = 0.522). No exploratory cancer-subgroup comparison met q < 0.05.Conclusions Pleuroparenchymal abnormalities are highly prevalent in cancer patients undergoing CTPA for suspected PE; however, most findings are nonspecific. Infarct-like wedge-shaped opacity generated the strongest exploratory PE-associated signal, but no individual imaging comparison survived multiplicity correction and model estimates remained imprecise. These findings should therefore be considered hypothesis-generating and require validation in larger cohorts.
SN - 2673-8740
ER -